All Activity

Wow, cool post. I'd like to write like this too - taking time and real hard work to make a great article... but I put things off too much and never seem to get started. Thanks though. https://www.aerogaga.com/

It is a good site post without fail. Not too many people would actually, the way you just did. I am impressed that there is so much information about this subject that has been uncovered and you’ve defeated yourself this time, with so much quality. Good Works! https://www.aerogaga.com/

Frequent goes to here i will discuss the obvious way to appreciate it on your attempt, which often is why Now i am viewing the internet site day-to-day, in search of completely new, useful facts. Quite a few, many thanks! live draw hk Certainly great, remarkable, fact-filled tips these. Ones own content articles Be required to fail, thinking that obviously is true these on top of that. One normally generate an intriguing browse. On earth do you enlighten So i'm shocked?: )#) Compete the great articles and reviews. toto slot login I had most recently initiated a fabulous web page, the details you will provide you with here comes with really helped others really. Regards just for all of the effort & succeed. slot gacor

This is a great post. I like this topic.This site has lots of advantage.I found many interesting things from this site. It helps me in many ways.Thanks for posting this again. https://www.aerogaga.com/

Frequent goes to here i will discuss the obvious way to appreciate it on your attempt, which often is why Now i am viewing the internet site day-to-day, in search of completely new, useful facts. Quite a few, many thanks! Mövenpick Siam Hotel Na Jomtien Pattaya Certainly great, remarkable, fact-filled tips these. Ones own content articles Be required to fail, thinking that obviously is true these on top of that. One normally generate an intriguing browse. On earth do you enlighten So i'm shocked?: )#) Compete the great articles and reviews. omacuan daftar I had most recently initiated a fabulous web page, the details you will provide you with here comes with really helped others really. Regards just for all of the effort & succeed. Plant Based Omega-3 Helpful — I valued the transparency on player complaint resolution timelines. Quick, fair resolution processes prevent toxic situations from escalating. Real votes showed which teams are responsive. slot online Positive site, where did u come up with the information on this posting? I'm pleased I discovered it though, ill be checking back soon to find out what additional posts you include. olxtoto Frequent goes to here i will discuss the obvious way to appreciate it on your attempt, which often is why Now i am viewing the internet site day-to-day, in search of completely new, useful facts. Quite a few, many thanks! Slot Deposit 5k

For casual use, the raz vape disposable device performs more consistently than expected.

I really impressed after read this because of some quality work and informative thoughts . I just wanna say thanks for the writer and wish you all the best for coming!. Businesworth

This type of message always inspiring and I prefer to read quality content, so happy to find good place to many here in the post, the writing is just great, thanks for the post. Businesworth

This is very educational content and written well for a change. It's nice to see that some people still understand how to write a quality post! Businesworth

“Congress, you have your marching orders from the president. Extend the implementation timeline for the hemp ban.” By Adam Terry, Cantrip As was widely reported to be imminent, last week just about the entire cannabis universe watched President Donald Trump sign an executive order to reschedule marijuana from Schedule I to Schedule III. What was not as widely reported was what Trump also did: He directed lawmakers to legislate again on the new definition of hemp as passed by Congress last month. The specific text from the executive order reads: “The Assistant to the President and Deputy Chief of Staff for Legislative, Political, and Public Affairs shall work with the Congress to update the statutory definition of final hemp-derived cannabinoid products to allow Americans to benefit from access to appropriate full-spectrum CBD products while preserving the Congress’s intent to restrict the sale of products that pose serious health risks…” This provision is careful and specific. It directs a deputy chief of staff to work with Congress to update the new definition of hemp in direct recognition of what the hemp industry has been saying for weeks now: Full-spectrum CBD products are not possible under this new language. It acknowledges specifically that if CBD products are to be subsidized or covered by Medicare, as is part of Trump’s plan, those products will be derived from hemp. Full-spectrum CBD is crucial to many Americans. It is a lifeline for veterans and seniors who rely on these products for a variety of therapeutic purposes. It is a crucial element for some with epilepsy, including pediatric patients. I have had mothers and fathers message me expressing that Epidiolex, a federally approved CBD prescription drug, simply did not work for their kids—and instead they relied on other CBD products to find relief for their children. This is not just politics for them, but a stark reality. You cannot have full-spectrum CBD with only 0.4mg of THC per container, as is required under the newly enacted change to the federal definition of hemp, and the president recognized this in his executive order—I’m sure with the counsel of groups like the Commonwealth Project who were present at the signing. Because of this, the definition of hemp is very likely to be reopened and legislated once more. So here’s the point: This conversation will take time, and likely more than is left for hemp ahead of the ban set to be enacted late next year. In the nearly three years I’ve been working with the New Jersey legislature to craft a bill to regulate hemp cannabinoids in a way that doesn’t decimate the CBD market, no law at the time of this writing has yet managed to take full effect in the state because of this complexity. This means that the best, first step Congress must take is to extend the deadline for the implementation of the revised hemp definition in order to ensure full spectrum CBD access remains for the tens of millions of Americans who will lose access next November should this language take effect. With 2026 being a tight election year, most legislation will be slowed to a crawl after April, and so it is unlikely that a final bill updating this language and regulating hemp cannabinoids could make it over the finish line until the next Congress beginning in January 2027. And the extension must pass soon, as farmers cannot plant in the spring if their crop will be a crime come harvest time. I look forward to the ensuing conversation. Hemp must be regulated in this country, that is clear. The White House just sent a signal that the prohibitionist redefinition cannot stand if we are to do right by the people who rely on cannabis the most, particularly across the red states that voted for this president and have no access to cannabis outside of hemp products. Congress, you have your marching orders from the president. Extend the implementation timeline for the hemp ban, and let’s do the real, hard work to craft legislation that enshrines safe access to cannabis for Americans across this great nation. Adam Terry is the co-founder and CEO of the THC-infused beverage company Cantrip. The post Trump’s Marijuana Order Means Congress Must Delay The Federal Hemp Ban’s Timeline (Op-Ed) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Delight in the highest satisfaction with our meticulously selected array of Kanpur's independent and agency-affiliated escorts, all of whom excel in delivering unparalleled gratification. Each partner offers a distinctive method for fulfilling your deepest desires, ensuring that every encounter is fresh, thrilling, and memorable. Escort Service Kanpur || Escort Service in Kanpur || Kanpur Escort || Escort in Kanpur || Kanpur Escort Service

Along with their talent and versatility, our escorts have extensive experience with us and possess a high level of education and sophistication. We understand that affluent and prosperous gentlemen seek a reliable Lucknow Escort Service to effortlessly and discreetly fulfill their desires. So, why delay? Contact us today to secure your enchanting perfect match.

Also creates an enjoyable rhythm that keeps stickman hook players mentally engaged. Each level follows a natural flow, where successful swings lead smoothly into the next challenge. This rhythm helps players develop a sense of anticipation and timing, which enhances immersion. Over time, players begin to move instinctively, reacting to hooks and obstacles almost automatically. This sense of rhythm is a hallmark of well-designed physics-based games.

Marijuana has therapeutic benefits for adults with disabilities and is commonly utilized to manage pain and other symptoms, a new government-funded study shows. “Cannabis use is prevalent across disability domains and the majority of respondents note they use cannabis to help with pain and to relax or relieve tension,” the researchers wrote. More than one in five people surveyed said they currently use cannabis—and the most commonly reported reason was relief of pain, at over 70 percent. More than 60 percent said marijuana helps to relax or relieve tension. “Specific medical reasons for using cannabis included assistance with health-related conditions such as migraines, nausea, muscle spasms, seizures, mental health concerns, and sleep disturbances,” the researchers wrote. The data and results were derived from the National Survey on Health and Disability, an annual measure of nearly 2,000 people who self-identify as living with a disability. The authors, affiliated with George Mason University and the University of Nevada, noted the methodology took into account participants’ self-reported limitations, including disabilities related to cognition, hearing, independent living, mobility, self-care and vision. The study was published in the November 2025 issue of the Disability and Health Journal. The researchers issued a note of caution regarding the study’s potential limitations, emphasizing that data were self-reported. “The cannabis use reason question does not ask specifically why respondents are currently using cannabis, and therefore respondents may have endorsed reasons for cannabis use in the past,” they wrote, adding that “the sample is not a representative sample and is majority white, female, college-educated, and affluent; therefore, the generalizability of these results to other demographics is unknown.” The study was funded by a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research, an agency within the National Institutes of Health. “We found that approximately one fifth of adults with disabilities had reported using cannabis currently.” Beyond cannabis’s direct effect in easing the symptoms of people with disabilities, legalization is helping in other ways. In recent years, for example, Colorado officials have prioritized funding programs for disabled communities with revenue generated by cannabis sales—most recently with an auction for marijuana-themed license plates. The post Medical Marijuana Use Is ‘Prevalent’ Among People With Disabilities—And It Helps Treat Pain, New Federally Funded Study Shows appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A bipartisan majority of Americans support federally rescheduling marijuana, according to a new poll. And most also believe it should be entirely legal for adults to use cannabis. The YouGov survey was released just days after President Donald Trump directed the attorney general to expeditiously complete the process of moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). The reform wouldn’t legalize cannabis, but it would symbolically recognize the plant’s medical value, while allowing marijuana businesses to take federal tax deductions and remove certain research barriers associated with Schedule I drugs. According to the poll, Americans are on board with the policy change. Here’s how the question was framed: “Do you approve or disapprove of the government reclassifying marijuana from the most restrictive category of drugs to a less restrictive category that allows for research on its potential medicinal uses?” Overall, 70 percent of respondents said they either “strongly” (42 percent) or “somewhat” (28 percent) approve of rescheduling. Just 16 percent said they oppose the reform, while 14 percent said they were unsure. Dec 19-22 poll of 31,080 U.S. adults (+/-0.8 point) % who approve | disapprove of the government reclassifying marijuana to a less restrictive category of drugs U.S. adults 70% | 16% Democrats 78% | 11% Independents 69% | 14% Republicans 66% | 21% (Link in reply) pic.twitter.com/tX36YE8xAZ — YouGov America (@YouGovAmerica) December 22, 2025 Notably, support crossed party lines, with 78 percent of Democrats, 69 percent of independents and 66 percent of Republicans in favor of reclassifying cannabis. The majority support is consistent with earlier polling, including one survey released earlier this year from a firm with ties to the president. YouGov also asked about the potential broader legalization of marijuana possession by adults, and a smaller majority (54 percent) said that should be permitted, including 68 percent of Democrats and 55 percent of independents. Republicans were evenly split on the question, with 41 percent in favor and 41 percent opposed. Separately, a majority of respondents (76 percent) also said marijuana either “definitely” (43 percent) or “probably” (33 percent) has “legitimate medical uses.” On that question, there was also bipartisan agreement. Democrats were most likely to say cannabis has medical value (84 percent), followed by independents (74 percent) and Republicans (73 percent). % who think that marijuana definitely or probably does | doesn't have legitimate medical uses U.S. adults 76% | 13% Democrats 84% | 9% Independents 74% | 12% Republicans 73% | 17%https://t.co/QeMPF23OF9 pic.twitter.com/zT2bNPqNHE — YouGov America (@YouGovAmerica) December 22, 2025 The survey involved interview with 31,080 U.S. adults from December 19-22, with a +/-0.8 percentage point margin of error. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — The rescheduling process initiated by the Biden administration, which Trump has now asked to be finalized, is still pending. But as prior polling has indicated—and this latest survey has reinforced—it’s a politically popular reform across the aisle. The president said last week that cannabis can “make people feel much better” and serve as a “substitute for addictive and potentially lethal opioid painkillers.” He clarified, however, that he personally has no interest in using marijuana himself. Trump also dismissed the concerns of GOP lawmakers who oppose rescheduling, pointing out that an overwhelming majority of Americans support the reform and that cannabis can help people—including his personal friends—who are suffering from serious health issues. Photo courtesy of Brian Shamblen. The post Bipartisan Majority Of Americans Support Rescheduling Marijuana And Say It Has Medical Value, New Poll Finds After Trump Takes Action appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Szukasz wiarygodnych informacji przed wyborem kasyna online?Znajdziesz tu rzetelne recenzje, aktualne rankingi oraz sprawdzone bonusy dla polskich graczy.Sprawdź kasyno online opinie https://legalne-kasyno.online/ i wybierz bezpieczną platformę do gry.

EU5 takes players to the most challenges.Your ultimate resource for Europa Universalis V mastery. Expert guides, professional reviews, and community insights all in one place.

“Our marijuana laws are stuck in the dark ages–overly punitive, out of step with our neighbors and holding our state back.” By Sam Stockard, Tennessee Lookout Tennessee lawmakers on both sides of the aisle are calling for new marijuana laws following President Donald Trump’s executive order to loosen cannabis restrictions. Democratic Sen. London Lamar of Memphis and Republican Rep. Jeremy Faison of Cosby in East Tennessee both said they believe the state needs reform after the president ordered the reclassification of marijuana to Schedule III from Schedule I on the Federal Drug Administration’s list of controlled substances, an indication it has medicinal value but still could be abused. Tennessee is one of 10 states that restricts medicinal and recreational marijuana while 22 other states have legalized some form of recreational use. Democratic Sen. London Lamar of Memphis said Tennessee lawmakers should take note of the federal move and pass new laws for medical use, decriminalization or legalization. “Our marijuana laws are stuck in the dark ages–overly punitive, out of step with our neighbors and holding our state back,” Lamar, chairman of the Senate Democratic Caucus, said in a statement. The state should support medical research of cannabis for treatment of patients who would choose it for pain medication over dangerous opioids, she said. Lamar added that the state also should stop wasting money incarcerating people for marijuana violations and divert those funds to roads, schools and healthcare. Faison, who previously pushed passage of medical marijuana laws, said the federal government never had a “sound justification for a naturally occurring plant” to be classified as a Schedule I drug. That made it comparable to heroin, LSD and Ecstasy. Nor did the federal government have a “solid basis to dictate” cannabis regulations to states, Faison said, adding the change brings a “safer, more practical” approach. “I truly hope that this fosters medical research that either debunks what many sick Americans have testified to or provides the evidence and foundation showing that cannabis is safer than opioids and other man-altered substances,” said Faison, chairman of the House Republican Caucus. But while the federal change is drawing bipartisan backing for new laws in Tennessee, Lt. Gov. Randy McNally said he has “no interest” in changing how the state schedules marijuana. McNally, an Oak Ridge Republican, pointed out that Schedule III drugs remain tightly regulated and can be dispensed only by a pharmacist at a doctor’s direction, usually for short-term use. He added that recommended dosages would have to be established and new rules set up for dispensing medical cannabis. “While the federal change does allow easier study and testing of the drug, I have no interest in changing how we schedule marijuana in Tennessee. In my mind it remains a dangerous drug with little demonstrated medicinal efficacy,” said McNally, who is also speaker of the Senate. Tennessee lawmakers who sought to pass medical marijuana laws previously ran into opposition from McNally, who said he couldn’t support a change because of the federal government’s Schedule I classification of cannabis. This story was first published by Tennessee Lookout. The post Bipartisan Tennessee Lawmakers Push For State-Level Marijuana Reform Following Trump’s Federal Rescheduling Move appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Many thanks with regard to supplying current improvements concerning the issue, We anticipate study much more. https://www.aerogaga.com/

Thanks for your time designed for advertisment a great very good guide! I noticed your internet-site ideal for a must have. It has splendid and even effective content articles. Compete the best get the job done! https://www.aerogaga.com/

Frequent goes to here i will discuss the obvious way to appreciate it on your attempt, which often is why Now i am viewing the internet site day-to-day, in search of completely new, useful facts. Quite a few, many thanks! 오피사이트 Certainly great, remarkable, fact-filled tips these. Ones own content articles Be required to fail, thinking that obviously is true these on top of that. One normally generate an intriguing browse. On earth do you enlighten So i'm shocked?: )#) Compete the great articles and reviews. mawarcuan88 daftar I had most recently initiated a fabulous web page, the details you will provide you with here comes with really helped others really. Regards just for all of the effort & succeed. KAVIAR88 Helpful — I valued the transparency on player complaint resolution timelines. Quick, fair resolution processes prevent toxic situations from escalating. Real votes showed which teams are responsive. 오피사이트 Positive site, where did u come up with the information on this posting? I'm pleased I discovered it though, ill be checking back soon to find out what additional posts you include. situs slot

Steal Brainrot offers nonstop action with meme humor, base raids, and deep progression systems. Can you survive the chaos? Play today!

It's so inspiring to read about Dutch Valley Farms and their commitment to sustainable practices and quality cannabis! It’s heartwarming to see a family-owned farm making such a positive impact not only in the cannabis community but also for families dealing with similar challenges. Their approach to farming and research is truly admirable. By the way, if you enjoy games with a bit of thrill, you might want to check out Snow Rider 3D for some fun escapism!

Ohio activists are launching a campaign to hit the brakes on a bill the governor recently signed to scale back the state’s voter-approved marijuana law and ban the sale of consumable hemp products outside of licensed cannabis dispensaries. Ohioans for Cannabis Choice said on Friday that they’d be collecting signatures for the statewide referendum, which would pause the implementation of SB 56 until voters got a say at the next regular or general election. Gov. Mike DeWine (R) has been adamant about cracking down on the unregulated intoxicating hemp market, but the legislation he signed would do more than restrict the sale of cannabinoid products to dispensaries. It would also recriminalize certain marijuana activity that was legalized under the ballot initiative voters approved in 2023, and it’d additionally remove anti-discrimination protections for cannabis consumers that were enacted under that law. The governor also used his line-item veto powers to cancel a section of the bill that would have delayed the implementation of the ban on hemp beverages. Advocates and stakeholders strongly protested the now-enacted legislation, arguing that it undermines the will of voters and would effectively eradicate the state’s hemp industry, as there are low expectations that adults will opt for hemp-based products over marijuana when they visit a dispensary. The pushback inspired the newly filed referendum—but the path to successfully blocking the law is narrow. Ohioans for Cannabis Choice must first collect an initial batch of 1,000 valid signatures, which would need to be certified by the secretary of state’s office, and then submit a total of about 250,000 signatures to make the ballot. “SB 56 forcefully defies the will of the voters of Ohio, who spoke clearly on this issue, and denies the people of Ohio the freedom to use these products for their personal use,” Dennis Willard, spokesperson for the campaign, said. “We are launching a referendum campaign to go directly to the voters,” he said. “We believe voters will say no to government overreach, no to closing 6,000 small businesses and pink-slipping thousands of workers across the state, and no to once again recriminalizing hemp and marijuana.” If activists reach the signature threshold by the deadline three months from now, which coincides with the same day the restrictive law is to take effect, SB 56 would not be implemented until voters got a chance to decide on the issue at the ballot. Advocates have flagged a series of concerns with the law, pointing out, for example, that it would eliminate language in statute providing anti-discrimination protections for people who lawfully use cannabis. That includes protections meant to prevent adverse actions in the context of child custody rights, the ability to qualify for organ transplants and professional licensing. It would also recriminalize possessing marijuana from any source that isn’t a state-licensed dispensary in Ohio or from a legal homegrow. As such, people could be charged with a crime for carrying cannabis they bought at a legal retailer in neighboring Michigan. Additionally, it would ban smoking cannabis at outdoor public locations such as bar patios—and it would allow landlords to prohibit vaping marijuana at rented homes. Violating that latter policy, even if it involves vaping in a person’s own backyard at a rental home, would constitute a misdemeanor offense. The legislation would also replace what had been a proposed regulatory framework for intoxicating hemp that the House had approved with a broad prohibition on sales outside marijuana dispensaries following a recent federal move to recriminalize such products. Under the law, hemp items with more than 0.4 mg of total THC per container, or those containing synthetic cannabinoids, could no longer be sold outside of a licensed marijuana dispensary setting. That would align with a recently enacted federal hemp law included in an appropriations package signed by President Donald Trump. The federal law imposing a ban on most consumable hemp products has a one-year implementation window, however, and it appears the Ohio legislation would take effect sooner. As passed by the legislature, a temporary regulatory program for hemp beverages would have stayed in place in Ohio until December 31, 2026, but that provision was vetoed by the governor. The law also includes language stipulating that, if the federal government moves to legalize hemp with higher THC content, it’s the intent of the Ohio legislature to review that policy change and consider potential state-level reforms to regulate such products. The bill signing came months after DeWine issued emergency rules prohibiting the sale of intoxicating hemp products for 90 days, with instructions to the legislature to consider permanent regulations. A county judge has enjoined the state from enforcing that policy in response to a legal challenge. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, in September, the Ohio Department of Cannabis Control (DCC) filed proposed rules to build upon the state’s marijuana legalization law, laying out plans to update regulations on labeling and packaging requirements. The proposal came weeks after Ohio medical and adult-use marijuana sales officially crossed $3 billion, data from the state Department of Commerce (DOC) shows. The state sold about $703 million in recreational cannabis in the law’s first year of implementation, according to DCC data. In March, a survey of 38 municipalities by the Ohio State University’s (OSU) Moritz College of Law found that local leaders were “unequivocally opposed” to earlier proposals that would have stripped the planned funding. Meanwhile in Ohio, adults as of June are able to buy more than double the amount of marijuana than they were under previous limits, with state officials determining that the market can sustainably supply both medical cannabis patients and adult consumers. The governor in March separately announced his desire to reallocate marijuana tax revenue to support police training, local jails and behavioral health services. He said funding police training was a top priority, even if that wasn’t included in what voters passed in 2023. The post Ohio Activists Plan Referendum To Block New Law Rolling Back Marijuana Rights And Restricting Hemp Sales appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A top Trump administration health official said last week that his agency will soon launch a novel program to have Medicare cover the costs of CBD for certain patients. But while the administration has not yet released specific details about the initiative’s rollout, one cannabis company that says it’s partnering with the government on the effort has since shed some light on what to expect. At a White House event last week, President Donald Trump signed an executive order directing the attorney general to complete the process of moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). But another major reform was also announced: A pilot program enabling eligible patients to access hemp-derived cannabidiol that’d be covered under federal health insurance plans, projected to launch by April. Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services (CMS), spoke about the initiative at the signing ceremony, crediting Trump and U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. for “pushing for change” and “relentlessly” pursuing an agenda rooted in a “deep passion for research.” Oz said Trump called him “frequently” to discuss the potential benefits of CBD after hearing from friends who “got relief” from the cannabinoid product, and per his direction, CMS has created “a new model” and taken “additional actions to give seniors access to cannabinoids.” “These are CBDs—they’re not addictive—which many are already using to manage pain,” he said. “There’s some clinical evidence that showing that CBDs provide relief from common conditions that affect Americans, including cancer symptoms and chronic pain and a slew of other problems that affect disproportionately seniors and our veterans.” There are relatively few specific details about the new model, however, and the CMS website hasn’t yet posted information about the rollout or who would specifically qualify. That said, Oz explained that the policy change will “allow millions of Americans on Medicare to become eligible to receive CBD as early as April of next year—and at no charge if their doctors recommend them.” One outstanding question concerns coverage eligibility. As described, it would affect those 65 and older who qualify for Medicare, but the specific qualifying conditions weren’t detailed. There was repeated mention of chronic pain, specifically related to cancer, but it’s possible the CBD eligibility criteria includes additional conditions. Marijuana Moment reached out to CMS for additional clarity about the plan, but representatives did not respond by the time of publication. At the Oval Office event, Oz said “sometimes these decisions are difficult,” and that while other presidents have “whiffed on this issue” because it’s “tough,” this administration is “passionate about making it clear that this patchwork that we’re working within now, the laws and regulations, they’re leaving patients and doctors without adequate guidance on the safeguards of how to use these products, even though they’re still being used.” The administrator added that Medicare Advantage insurers CMS has contacted are “also agreeing to consider CBD to be used for the 34 million Americans that they cover.” “If you can hear my voice and you’re over 65, you should pay attention to this executive order, because it’s going to touch your life,” Oz said. “Again, this all becomes active after the first quarter of next year. These CBD products must first meet local and state quality and safety standards. They must come from legitimate sources. They must abide by other regulations of those states with these boxes checked.” He said patients can be reimbursed for up to $500 worth of hemp-derived cannabinoid products per year, and CMS will be collecting data on the patient outcomes and making the data publicly available to analyze. “If it shows promise, we will expand access to these products to even more conditions amongst Medicare [and] Medicaid beneficiaries,” he said. Oz also gave kudos to Howard Kessler, founder of The Commonwealth Project, which produced a video about the benefits of cannabidiol for seniors that Trump shared on Truth Social earlier this year and who apparently has pressed the president to enact reform to expand cannabis access. One company that says it will be participating in the CBD pilot program is Charlotte’s Web, which has long advocated for reform and focused on the therapeutic potential of cannabinoids for people with severe epilepsy. CEO Bill Morachnick said in a press release that the business is “proud” to “bring trusted CBD options to underserved seniors battling cancer” through the initiative. “Charlotte’s Web was founded to help Charlotte Figi, whose medically challenging life became a CBD success story,” he said. “Her journey inspired research, opened doors to access, and changed perceptions about the therapeutic benefits of CBD around the globe.” “The Company made a promise to Charlotte, her mother Paige, and the millions who followed her: to set the standard for the entire industry by leading with quality, consistency, and science,” he said. “As the CBD market leader and a trusted partner throughout the country among healthcare practitioners, this initiative marks a historic step forward, uniquely positioning Charlotte’s Web to expand access to safe, non-intoxicating hemp CBD products through existing pathways.” “This initiative represents a blueprint for patient-centered CBD healthcare—one that advances alongside our medical channel expansion and deepening clinical research. The potential of the hemp plant is still being furthered, and studies like the Phase 2 FDA clinical trials investigating hemp-based therapies for autism spectrum disorder at our affiliated company, DeFloria, are critical to making its therapeutic promise even more accessible for health insurance-covered care. Our work through this program and our ongoing research demonstrate how rigorous science and compassionate care can converge to serve patients who need it most.” “This pilot program would inform potential expansion into other patient populations to use CBD to support sleep, anxiety, pain, and general wellness as identified in the Federal Register,” the company said, referencing a recent notice from CMS about its existing plans to authorize health insurance coverage for CBD under certain Medicare programs. While CMS implemented an earlier 2026 final rule in April specifically stipulating that marijuana, as well as CBD that can be derived from federally legal hemp, are ineligible for coverage under its Medicare Advantage program and other services, the agency has since revised that policy. The Commonwealth Project estimates that 8,000-12,000 patients will participate in the program, with projections of up to $64 billion in “potential annual savings through improved symptom management and reduced reliance on certain high-cost interventions,” according to information in a press pitch on behalf of Charlotte’s Web. While Oz said April 2026 is when eligible patients will be able to take advantage of the policy change, the hemp stakeholders’ press pitch said the pilot program itself is set to launch in January. Marcel Bonn-Miller, chief scientific officer at Charlotte’s Web, said “scientific rigor underpins every aspect of this program.” “With more than a decade of consumer use and extensive safety studies, Charlotte’s Web integrates real-world evidence, patient-reported outcomes, and clinical insights into its R&D process to ensure products are safe and effective,” he said. Meanwhile, following the White House announcement last week, Oz spoke with NewsNation about the policy change, responding to a question about how the broader marijuana rescheduling decision squares with the Trump administration’s aggressive efforts to stymie the flow of other illicit drugs, particularly fentanyl. “We think they fit hand in hand,” he said. “This is really about researching—specifically CBD, which is hemp-derived endocannabinoids [sic]—are actually worthy of Americans using them,” he said. “It’s hard to do some of this work, especially with medical marijuana. And this is not about legalization of marijuana.” “There is no legalization language at all,” he added. “It’s about rescheduling this class of product so that it can be researched more readily.” The idea that marijuana has no medical value, as its currently defined as a Schedule I drug, is “just patently wrong for marijuana,” he said, noting that the Food and Drug Administration (FDA) has approved certain cannabis-based drugs for conditions such as epilepsy “that work quite nicely.” “That belief that it should be Schedule I is just an incorrect place to put it,” he said. “Schedule III seemed to make sense to the president. He argued that it allows us to do the research more readily.” “We’re finding a way to allow Medicare beneficiaries to get access to some of these products. And so, within Medicare, we have the ability, for the first time ever—and we delivered on this promise to the president today—to allow doctors to recommend hemp-derived CBD for patients who have cancer, for example, and have a lot of pain from that.” The administrator said surveys show a majority of seniors who take CBD for pain management find it beneficial, and the White House wants to “make it easier for patients to access this” and allow them to access the cannabinoid at “no charge” through the federal health insurance program. “If it works well, we’re going to get a lot of data—and we’ll know a ton more about whether this truly makes a difference for the American people,” Oz said. “But again, I want to emphasize this: I don’t like marijuana smell walking down the streets. The president doesn’t either.” Trump and Kennedy “don’t drink, so they definitely don’t smoke marijuana. So this is not about legalizing these products,” he said. In recent years, Dr. Oz has encouraged audiences to be open to therapeutic cannabis and advocated for sweeping policy changes around the drug. “We ought to completely change our policy on marijuana. It absolutely works,” he said in a 2020 interview, calling cannabis “one of the most underused tools in America.” Last year, he wrote in a syndicated health column that there’s evidence cannabinoids can curb seizures, alleviate nausea associated with cancer treatment and potentially help manage pain—especially in older people. Oz also said in 2020 that he believes that, particularly for seniors, marijuana for pain represents a “safer solution than, for example, narcotics in many cases.” The post Federal Health Programs Will Cover Up To $500 Worth Of CBD For Certain Patients By April, Trump Official Dr. Oz Says appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net